Primary Rodent Production Center

美国国家癌症研究所（NCI）管理着一项生产实验动物的计划，以支持NCI/NIH的许多癌症研究活动。这些机构包括美国国立卫生研究院校园实验室、美国国立卫生研究院/美国国立卫生研究院资助的研究承包商、美国国立卫生研究院/美国国立卫生研究院资助的受资助者、其他政府机构以及国外的合作者。动物生产项目由生物测试科（BTB）、发育治疗科（DTP）、癌症治疗和诊断科（DCTD）管理。生产基因确定和无病原体的实验动物需要严格的屏障建设和隔离操作，以提供所需的动物质量。为了尽量减少实验研究中的变量，这项工作的质量至关重要。生产没有致病微生物的高质量啮齿动物是这项工作的主要目标。提供动物是为了支持癌症、传染病、生物恐怖主义威胁和其他国家公认的健康问题的病因和治疗研究。

The National Cancer Institute (NCI) administers a program to produce laboratory animals in support of many NCI/NIH cancer research activities. These include NIH on-campus laboratories, NCI/NIH-funded research contractors, NCI/NIH-funded grantees, other governmental agencies as well as collaborators in foreign countries. The Animal Production Program is managed by the Biological Testing Branch (BTB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD). The production of genetically-defined and pathogen-free laboratory animals requires strict barrier building and isolator operations to provide the required quality of animals. The quality of this effort is of critical importance in order to minimize variables within experimental studies. The production of the highest quality rodents free from pathogenic organisms is the primary objective of this effort. Animals are provided to support research in the cause and treatment of cancer, infectious disease, bioterrorism threat and other nationally recognized health issues.